In 2024, HIV-AIDS mortality in the US is forecasted at 3.66 thousand male deaths, declining annually to 3.49 thousand by 2028. This signifies a year-on-year decrease of approximately 1.2% and a compounded annual growth rate (CAGR) decline of around 1.16% from 2024 to 2028, using 2023 as the reference year. This trend suggests a gradual improvement in healthcare interventions and treatments for HIV-AIDS.
Future trends to watch for include potential breakthroughs in HIV treatments and increased access to preventive measures, which could accelerate the decline in mortality rates further. Additionally, public health strategies focusing on awareness and education might also impact these figures positively.
